Lochmüller Lab seeking PhD student

The Lochmüller Research Group are seeking a highly motivated PhD student to join our team at the Childrens Hospital of Eastern Ontario Research Institute (CHEO RI). The project, part of the recently funded Brain-Heart Initiative at uOttawa, will involve working with advanced cell models to perform drug screens, biomarker studies, and mechanistic investigations into Myotonic Dystrophy Type 1 (DM1). Candidates with previous laboratory experience, particularly in cell culture and molecular biology are particularly encouraged to apply.

Check out the full description of the PhD opportunity.

Research Environment

The Lochmüller Research Group specializes in conducting scientific, genetic, and clinical investigations into neuromuscular disorders, while also providing clinical support for individuals affected by these conditions. Our primary objective is to unravel the reasons behind genetic variations in the human genome give rise to these often debilitating, and occasionally life-threatening disorders that impact the muscles and nervous system. Employing a translational approach from laboratory research to practical applications, we identify genetic defects in patients through in-depth phenotyping and next-generation sequencing. Subsequently, we delve into understanding molecular pathways using cell and animal models before progressing to preclinical and clinical trials testing innovative targeted therapies. The CHEO Research Institute is located in Ottawa, sharing a campus with the University of Ottawa, The Ottawa Hospital Research Institute, and the CHEO hospital. This arrangement fosters valuable collaboration among various groups, facilitating the exchange of resources and equipment. Ottawa provides a vibrant, inclusive, cost-effective, and friendly atmosphere for both academic pursuits and daily life. Additionally, the city benefits from excellent transportation links, both internally and to other Canadian cities.

Entry Requirements

Candidates are expected to hold or be about to obtain a MSc degree in a related subject/area. In addition, to selection by the Lochmüller Research group, candidates will need to apply to The University of Ottawa CMM program and fulfil their entry requirements.

How to Apply

If you are interested, please send you CV, Transcripts, and cover letter explaining why you are interested in this opportunity to Dr Sally Spendiff at . Applications should be submitted by the 8th of March. 

 

Copy of Lochmuller Lab - PhD opportunity (LLab)

Read next...

Text reading: Solve-RD publication: Solve-RD flagship publication: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses. Photos of Dr Kiran Polavarapu, Dr Rachel Thompson, Dr Hanns Lochmüller.

Solve-RD flagship publication in Nature Medicine: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses

Patients and families with rare disorders often remain without a genetic diagnosis despite modern advances in diagnostic testing. Due to the rarity and global distribution...
New publication: Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis . Author's photos on the right, diagram from paper underneath title.

New Lab Publication Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis

Rhabdomyolysis is an acute failure of cellular homeostasis characterized by acute skeletal muscle damage triggered by trauma, infection, drugs, or strenuous exercise. Recurrent rhabdomyolysis is...
New lab publication on riboflavin transporter deficiency model

New Publication: Development of a riboflavin-responsive model of riboflavin transporter deficiency in zebrafish

Riboflavin transporter deficiency (RTD) is a rare genetic disorder in children, characterised by progressive sensorimotor and cranial neuronopathy caused by mutations in riboflavin transporter protein-encoding...
Congratulations CNMD Ottawa on 25 years of neuromuscular research. Photo of all former and current directors of the Centre.

uOttawa Eric Poulin Centre for Neuromuscular Disease Celebrates 25 Years of Neuromuscular Research

New co-directors Dr Mireille Khacho and Dr Hanns Lochmüller begin their tenure On November 25th the University of Ottawa Eric Poulin Centre for Neuromuscular Disease...
Clinical trial update - Canadian Patient First in the World to Receive Trial Drug in Argenx DOK7-CMS Study

Canadian Patient Dosed in Argenx DOK7-CMS Study

Our clinical research team at the NeuroMuscular centre of The Ottawa Hospital is excited to share that a Canadian patient affected by DOK-7 Congenital Myasthenic...
New lab publication - Brain malformations and seizures by impaired chaperonin function of TRiC

New Publication: Brain malformations and seizures by impaired chaperonin function of TRiC

We are excited to share a new publication from our research team! The study “Brain malformations and seizures by impaired chaperonin function of TRiC” uncovers...